Cargando…
Valproic Acid-induced Hyperammonemic Encephalopathy Promoted by Levetiracetam
Encephalopathy resulting from the administration of levetiracetam (LEV) is a rare occurrence. We experienced a patient receiving LEV treated with valproic acid (VPA) for partial seizures with secondary generalization, following which she developed hyperammonemic encephalopathy and showed complete re...
Autores principales: | Roh, Sook Young, Jang, Hyun-soon, Jeong, Eun Hye, Kim, Byung-Su, Sunwoo, Moon Kyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Epilepsy Society
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295059/ https://www.ncbi.nlm.nih.gov/pubmed/25625094 http://dx.doi.org/10.14581/jer.14017 |
Ejemplares similares
-
Hyperammonemic Encephalopathy due to Valproic Acid and Topiramate Interaction
por: Twilla, Jennifer D., et al.
Publicado: (2014) -
A Case of Valproic-Acid Induced Hyperammonemic Encephalopathy
por: Iqbal, Kinza, et al.
Publicado: (2021) -
Hyperammonemic Encephalopathy: valproic acid-induced adverse reaction
por: Gómez, E., et al.
Publicado: (2023) -
Valproic acid-induced hyperammonemic encephalopathy: a clinical case
por: Felizardo, M., et al.
Publicado: (2022) -
Valproic-induced Hyperammonemic Encephalopathy in a Known Case of Epilepsy
por: Imam, Syed F, et al.
Publicado: (2017)